INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue For Q4 2023

Table of Contents hide

1 INmune Bio 2023 Q4 Earnings Report

1.1 The Financial Misstep of INmune Bio

INmune Bio Q4 2023: A Financial Stumble in the Dark

INmune Bio 2023 Q4 Earnings Report

INMB stock - INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

The Financial Misstep of INmune Bio

INmune Bio (NASDAQ:INMB) recently unveiled its financial performance for the final quarter of 2023:

Reported earnings per share stood at -47 cents, falling short of the projected -44 cents.
Revenue figures showed $28,000, a notable 30% dip compared to the anticipated $40,000.

InvestorPlace Earnings, powered by TradeSmith data, delivers automated updates on quarterly earnings. By swiftly sharing crucial insights like EPS and revenue, it offers a snapshot of a company’s performance against analyst forecasts. These reports are generated without human intervention to swiftly disseminate the latest financials. To flag any concerns or inaccuracies, reach out to us at editor@investorplace.com.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/inmb-stock-earnings-inmune-bio-for-q4-of-2023/.

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Actionable Trade Ideas

INmune Bio 2023 Q4 Earnings Report

The Financial Misstep of INmune Bio

Swing Trading Ideas and Market Commentary

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Related Articles

WallStreet Waves

most Popular

trending right now